Sera Prognostics Inc.

SERA | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.21

+$0.09 (+4.25%)

Sep 22, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+4.25%

(1D)

Rating

Updated: Aug 14, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $84.4M

1D Range

2.07 2.22

52W Range

1.56 3.95

Valuation (TTM)

PE -3.16

PB 1.36

EV/EBITDA -1.16

Valuation (NTM)

Forward PE N/A

Forward PEG 0.17

Price Target $6

Cash Flow

FCF Yield -34.8%

SBC Adj. FCF Yield -39.6%

SBC Impact -14.0%

Margins

Gross Margin -150.0%

Operating Margin -53282.9%

FCF Margin -40211.4%

Growth (CAGR)

Revenue 3Y | 5Y -42.9% | 9.7%

Dil EPS 3Y | 5Y 18.6% | 20.7%

FCF 3Y | 5Y -25.5% | 8.3%

Returns

ROA -38.3%

ROE -46.7%

ROIC -59.8%

Financial Health

Net Cash

$46.45M

Current Ratio 1.98

Interest Coverage -5,328.29

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 72

IPO Date Jul 14, 2021

Website www.sera.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞